Left ventricular mass and shortening fraction were measured by echocardiography ... Pompe disease because of the early mortality observed in untreated patients; the interpretation of the findings ...

Amicus Therapeutics could be just weeks away from getting EU approval for its new Pompe disease therapy Pombiliti after getting a positive opinion on the drug from the EMA's human medicines committee.